An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug

BACKGROUND: Coronavirus Disease 2019 (COVID-19) is a pandemic affecting all countries in the world. Italy has been particularly afflicted by the health emergency, and since the peak phase has passed, major concern regarding medium to long term complications due to COVID-19 is arising. Little is know...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Elia, Emilia, Gori, Mauro, Grosu, Aurelia, Iorio, Annamaria, Lorini, Ferdinando Luca, Falanga, Anna, Di Marco, Fabiano, Senni, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988245/
https://www.ncbi.nlm.nih.gov/pubmed/33761886
http://dx.doi.org/10.1186/s12890-021-01453-2
_version_ 1783668756633878528
author D’Elia, Emilia
Gori, Mauro
Grosu, Aurelia
Iorio, Annamaria
Lorini, Ferdinando Luca
Falanga, Anna
Di Marco, Fabiano
Senni, Michele
author_facet D’Elia, Emilia
Gori, Mauro
Grosu, Aurelia
Iorio, Annamaria
Lorini, Ferdinando Luca
Falanga, Anna
Di Marco, Fabiano
Senni, Michele
author_sort D’Elia, Emilia
collection PubMed
description BACKGROUND: Coronavirus Disease 2019 (COVID-19) is a pandemic affecting all countries in the world. Italy has been particularly afflicted by the health emergency, and since the peak phase has passed, major concern regarding medium to long term complications due to COVID-19 is arising. Little is known in literature regarding thromboembolic complications once healed after COVID-19. CASE PRESENTATION: A 51-year-old patient recovered from COVID-19 pneumonia complicated by pulmonary embolism (PE) came to the hospital for palpitations and chest pain. Although he was on treatment dose of direct oral anticoagulation (DOAC), massive recurrent PE was diagnosed. CONCLUSION: In the early post COVID-19 era, the question remains regarding the efficacy of DOACs in COVID-19 patients.
format Online
Article
Text
id pubmed-7988245
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79882452021-03-24 An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug D’Elia, Emilia Gori, Mauro Grosu, Aurelia Iorio, Annamaria Lorini, Ferdinando Luca Falanga, Anna Di Marco, Fabiano Senni, Michele BMC Pulm Med Case Report BACKGROUND: Coronavirus Disease 2019 (COVID-19) is a pandemic affecting all countries in the world. Italy has been particularly afflicted by the health emergency, and since the peak phase has passed, major concern regarding medium to long term complications due to COVID-19 is arising. Little is known in literature regarding thromboembolic complications once healed after COVID-19. CASE PRESENTATION: A 51-year-old patient recovered from COVID-19 pneumonia complicated by pulmonary embolism (PE) came to the hospital for palpitations and chest pain. Although he was on treatment dose of direct oral anticoagulation (DOAC), massive recurrent PE was diagnosed. CONCLUSION: In the early post COVID-19 era, the question remains regarding the efficacy of DOACs in COVID-19 patients. BioMed Central 2021-03-24 /pmc/articles/PMC7988245/ /pubmed/33761886 http://dx.doi.org/10.1186/s12890-021-01453-2 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
D’Elia, Emilia
Gori, Mauro
Grosu, Aurelia
Iorio, Annamaria
Lorini, Ferdinando Luca
Falanga, Anna
Di Marco, Fabiano
Senni, Michele
An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug
title An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug
title_full An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug
title_fullStr An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug
title_full_unstemmed An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug
title_short An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug
title_sort unexpected case of recurrence of pulmonary embolism in a patient recovered from covid19 in full regimen dose of direct oral anticoagulant drug
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988245/
https://www.ncbi.nlm.nih.gov/pubmed/33761886
http://dx.doi.org/10.1186/s12890-021-01453-2
work_keys_str_mv AT deliaemilia anunexpectedcaseofrecurrenceofpulmonaryembolisminapatientrecoveredfromcovid19infullregimendoseofdirectoralanticoagulantdrug
AT gorimauro anunexpectedcaseofrecurrenceofpulmonaryembolisminapatientrecoveredfromcovid19infullregimendoseofdirectoralanticoagulantdrug
AT grosuaurelia anunexpectedcaseofrecurrenceofpulmonaryembolisminapatientrecoveredfromcovid19infullregimendoseofdirectoralanticoagulantdrug
AT iorioannamaria anunexpectedcaseofrecurrenceofpulmonaryembolisminapatientrecoveredfromcovid19infullregimendoseofdirectoralanticoagulantdrug
AT loriniferdinandoluca anunexpectedcaseofrecurrenceofpulmonaryembolisminapatientrecoveredfromcovid19infullregimendoseofdirectoralanticoagulantdrug
AT falangaanna anunexpectedcaseofrecurrenceofpulmonaryembolisminapatientrecoveredfromcovid19infullregimendoseofdirectoralanticoagulantdrug
AT dimarcofabiano anunexpectedcaseofrecurrenceofpulmonaryembolisminapatientrecoveredfromcovid19infullregimendoseofdirectoralanticoagulantdrug
AT sennimichele anunexpectedcaseofrecurrenceofpulmonaryembolisminapatientrecoveredfromcovid19infullregimendoseofdirectoralanticoagulantdrug
AT deliaemilia unexpectedcaseofrecurrenceofpulmonaryembolisminapatientrecoveredfromcovid19infullregimendoseofdirectoralanticoagulantdrug
AT gorimauro unexpectedcaseofrecurrenceofpulmonaryembolisminapatientrecoveredfromcovid19infullregimendoseofdirectoralanticoagulantdrug
AT grosuaurelia unexpectedcaseofrecurrenceofpulmonaryembolisminapatientrecoveredfromcovid19infullregimendoseofdirectoralanticoagulantdrug
AT iorioannamaria unexpectedcaseofrecurrenceofpulmonaryembolisminapatientrecoveredfromcovid19infullregimendoseofdirectoralanticoagulantdrug
AT loriniferdinandoluca unexpectedcaseofrecurrenceofpulmonaryembolisminapatientrecoveredfromcovid19infullregimendoseofdirectoralanticoagulantdrug
AT falangaanna unexpectedcaseofrecurrenceofpulmonaryembolisminapatientrecoveredfromcovid19infullregimendoseofdirectoralanticoagulantdrug
AT dimarcofabiano unexpectedcaseofrecurrenceofpulmonaryembolisminapatientrecoveredfromcovid19infullregimendoseofdirectoralanticoagulantdrug
AT sennimichele unexpectedcaseofrecurrenceofpulmonaryembolisminapatientrecoveredfromcovid19infullregimendoseofdirectoralanticoagulantdrug

Ejemplares similares